Informative presence and observation in routine health data: A review of methodology for clinical risk prediction.

clinical prediction model electronic health records informative observation informative presence

Journal

Journal of the American Medical Informatics Association : JAMIA
ISSN: 1527-974X
Titre abrégé: J Am Med Inform Assoc
Pays: England
ID NLM: 9430800

Informations de publication

Date de publication:
15 01 2021
Historique:
received: 26 06 2020
accepted: 17 09 2020
pubmed: 10 11 2020
medline: 8 6 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

Informative presence (IP) is the phenomenon whereby the presence or absence of patient data is potentially informative with respect to their health condition, with informative observation (IO) being the longitudinal equivalent. These phenomena predominantly exist within routinely collected healthcare data, in which data collection is driven by the clinical requirements of patients and clinicians. The extent to which IP and IO are considered when using such data to develop clinical prediction models (CPMs) is unknown, as is the existing methodology aiming at handling these issues. This review aims to synthesize such existing methodology, thereby helping identify an agenda for future methodological work. A systematic literature search was conducted by 2 independent reviewers using prespecified keywords. Thirty-six articles were included. We categorized the methods presented within as derived predictors (including some representation of the measurement process as a predictor in the model), modeling under IP, and latent structures. Including missing indicators or summary measures as predictors is the most commonly presented approach amongst the included studies (24 of 36 articles). This is the first review to collate the literature in this area under a prediction framework. A considerable body relevant of literature exists, and we present ways in which the described methods could be developed further. Guidance is required for specifying the conditions under which each method should be used to enable applied prediction modelers to use these methods. A growing recognition of IP and IO exists within the literature, and methodology is increasingly becoming available to leverage these phenomena for prediction purposes. IP and IO should be approached differently in a prediction context than when the primary goal is explanation. The work included in this review has demonstrated theoretical and empirical benefits of incorporating IP and IO, and therefore we recommend that applied health researchers consider incorporating these methods in their work.

Identifiants

pubmed: 33164082
pii: 5961436
doi: 10.1093/jamia/ocaa242
pmc: PMC7810439
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-166

Subventions

Organisme : Medical Research Council
ID : MC_UU_00002/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013751/11
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association.

Références

Stud Health Technol Inform. 2017;235:261-265
pubmed: 28423794
BMC Med Inform Decis Mak. 2019 Jan 10;19(1):7
pubmed: 30630486
Am J Epidemiol. 2016 Dec 1;184(11):847-855
pubmed: 27852603
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:3660-3663
pubmed: 29060692
Biometrics. 2016 Dec;72(4):1315-1324
pubmed: 26990830
BMC Med Res Methodol. 2020 Apr 26;20(1):94
pubmed: 32336264
Stat Neerl. 2020 Feb;74(1):5-23
pubmed: 31894164
J Clin Epidemiol. 2020 May;121:110-112
pubmed: 32004672
Stat Med. 2017 Jul 30;36(17):2750-2763
pubmed: 28464332
J Clin Epidemiol. 2020 Sep;125:183-187
pubmed: 32540389
Sci Data. 2016 May 24;3:160035
pubmed: 27219127
EGEMS (Wash DC). 2016 Aug 31;4(1):1203
pubmed: 27668265
Diagn Progn Res. 2020 Jul 2;4:8
pubmed: 32699824
JMIR Med Inform. 2019 Jan 08;7(1):e11605
pubmed: 30622091
ACM BCB. 2016 Oct;2016:337-344
pubmed: 32577627
Biometrics. 2017 Jun;73(2):625-634
pubmed: 27548645
Stat Med. 2017 Dec 10;36(28):4514-4528
pubmed: 27730661
Stat Med. 2014 Nov 30;33(27):4770-89
pubmed: 25052289
J Biomed Inform. 2018 Jul;83:167-177
pubmed: 29883623
Stat Med. 2018 Dec 20;37(29):4457-4471
pubmed: 30112825
NPJ Digit Med. 2019 Apr 30;2:31
pubmed: 31304378
Stat Methods Med Res. 2016 Aug;25(4):1579-95
pubmed: 23804968
Stat Med. 2008 Nov 29;27(27):5725-44
pubmed: 18646254
BMJ. 2018 Apr 30;361:k1479
pubmed: 29712648
AMIA Annu Symp Proc. 2015 Nov 05;2015:1371-80
pubmed: 26958278
Stat Med. 2018 Dec 10;37(28):4142-4154
pubmed: 30073700
J Biomed Inform. 2008 Feb;41(1):1-14
pubmed: 17625974
EGEMS (Wash DC). 2017 Dec 06;5(1):22
pubmed: 29930963
Stat Methods Med Res. 2016 Dec;25(6):2992-3014
pubmed: 24855119
J Clin Epidemiol. 2020 Nov;127:191-197
pubmed: 32726605
Biostatistics. 2020 Apr 1;21(2):236-252
pubmed: 30203058
Stat Methods Med Res. 2019 Feb;28(2):327-342
pubmed: 28750578
J Am Med Inform Assoc. 2017 Jan;24(1):198-208
pubmed: 27189013
J Am Med Inform Assoc. 2019 Dec 1;26(12):1609-1617
pubmed: 31553474
BMC Med Res Methodol. 2016 Sep 07;16(1):117
pubmed: 27604810
Biometrics. 2008 Sep;64(3):950-8
pubmed: 18162110
Sci Rep. 2018 Apr 17;8(1):6085
pubmed: 29666385
Biom J. 2018 May;60(3):583-596
pubmed: 29468723
BMJ Open. 2019 Jun 24;9(6):e028101
pubmed: 31239303
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Annu Int Conf IEEE Eng Med Biol Soc. 2015 Aug;2015:1616-20
pubmed: 26736584
Biometrics. 2011 Sep;67(3):819-29
pubmed: 21306352
Stat Med. 2019 Jan 15;38(1):74-87
pubmed: 30252148
J Clin Epidemiol. 2020 Sep;125:188-190
pubmed: 32565213
Diagn Progn Res. 2020 Jul 9;4:9
pubmed: 32671229
AMIA Annu Symp Proc. 2013 Nov 16;2013:1472-7
pubmed: 24551421
Clin Chem. 2009 May;55(5):994-1001
pubmed: 19282357
JMIR Med Inform. 2017 Mar 03;5(1):e7
pubmed: 28258046
IEEE J Biomed Health Inform. 2020 Feb;24(2):424-436
pubmed: 31331898
Biometrics. 2016 Sep;72(3):907-16
pubmed: 26890381
Stat Methods Med Res. 2020 May;29(5):1466-1479
pubmed: 31347460

Auteurs

Rose Sisk (R)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, University of Manchester, Manchester, United Kingdom.

Lijing Lin (L)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, University of Manchester, Manchester, United Kingdom.

Matthew Sperrin (M)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, University of Manchester, Manchester, United Kingdom.

Jessica K Barrett (JK)

MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Brian Tom (B)

MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.

Karla Diaz-Ordaz (K)

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Niels Peek (N)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, University of Manchester, Manchester, United Kingdom.
NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.
Alan Turing Institute, University of Manchester, London, United Kingdom.

Glen P Martin (GP)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, University of Manchester, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH